Invitrogen™ Kit ELISA for MMP-9 equine

Ref.: BL-RE-106100Manufacturer ref.: EE5RBX10 10 x 96 tests
Price on request
Custom pricing depending on configuration and quantity.

MMP9 (matrical metallopeptidase 9, GELB, CLG4B) is a matrix metalloprotease, a zinc- and calcium-dependent d Looksupptidases family that degrade extracellular matrix proteins. MMP9 is secreted as a...

Accession number
Q13478
Dose range
49 to 12 000 pg/ml
Sensitivity of the dosage
49 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

MMP9 (matrical metallopeptidase 9, GELB, CLG4B) is a matrix metalloprotease, a zinc- and calcium-dependent d Looksupptidases family that degrade extracellular matrix proteins. MMP9 is secreted as a...

MMP9 (matrical metallopeptidase 9, GELB, CLG4B) is a matrix metalloprotease, a zinc- and calcium-dependent d Looksupptidases family that degrade extracellular matrix proteins. MMP9 is secreted as a 92 kDa zymogen and the cleavage of pro-MMP9 results in an active enzyme with a molecular weight of 82 kDa. MMP9 has a gelatin binding domain consisting of three type II fibronectin units, a catalytic domain containing the zinc binding site, a proline-rich type V collagen homologous domain and a similar domain to l'hemopexin. MMP9 is produced by monocytes, macrophages, neutrophils, keratinocytes, fibroblasts, osteoclasts and endothelial cells, and is involved in inflammatory responses, tissue remodeling, wound healing, tumour growth, and metastases. MMP9 is provided by cells derived from the bone marrow and contributes to skin carcinogens. In addition, MMP9 degrades collagens of type IV and V. Studies in rhesus monkeys suggest that the enzyme is involved in l-IL-8-induced mobilization of bone marrow hematopoietic stem cells, and studies in murine models suggest a role in remodeling tumour-associated tissues. Studies have shown that high MMP9 levels are associated with progression of idiopathic atrial fibrillation and aortic aneurysm.

Sensitivity

Sensitivity of the dosage: 49 pg/ml.

Measurement range

Dose range: 49 to 12,000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: MMP-9.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17717533
Specifications
Accession numberQ13478
Dose range49 to 12 000 pg/ml
Sensitivity of the dosage49 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)100056599
Gene symbol(s)MMP9
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate.
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetMMP-9
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 μl-Plasma, 50 μl-Surnatant, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EE5RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.